• Flexipharm Austrading launches APML therapy in UK pharmaceutical-technology
    May 22, 2019
    Flexipharm Austrading has launched the Arsenic Trioxide Phebra injection for the treatment of acute promyelocytic leukaemia (APML) after securing Medicines and Healthcare products Regulatory Agency (MHRA) marketing authorisation.
PharmaSources Customer Service